Current Funding Opportunities

Free to Breathe Issues Request for Proposals for Lung Cancer Research
Free to Breathe, a partnership of lung cancer survivors, advocates, researchers, healthcare professionals, and industry leaders united in the belief that every person with lung cancer deserves a cure, has issued a Request for Proposals for research projects focused on preventing or stopping lung cancer metastasis.
Grants of up to $600,000 over three years will be awarded in support of innovative, high-impact lung cancer research that leads to clinical translation (e.g. clinical trial) by the end of the award period. The partnership is particularly interested in proposals that include interdisciplinary teams and two or more principal investigators; collaborations with industry partners (PIs must be employed at a nonprofit entity such as an academic or research institution); access to existing patient samples or data, especially tissue from metastatic sites; studies that include mechanistic investigations into the underlying causes of metastasis; studies that are distinct research components of new or existing clinical trials; and/or novel approaches for preventing brain metastasis.

Application Deadline: November 7, 2014

Learn More >> (PDF)

Conquer Cancer Foundation - Career Development Award
The Career Development Award (CDA) is a research grant that provides funding to clinical investigators who have received their initial faculty appointment to establish an independent clinical cancer research program. The cancer research must have a patient-oriented focus, including a clinical research study and/or translational research involving human subjects.

Application Deadline: September 25, 2014

Learn More >>

NCCN Research Grant
National Comprehensive Cancer Network® (NCCN®) is pleased to announce that it has received a $2 million research grant from Boehringer Ingelheim Pharmaceuticals, Inc. to support NCCN investigator initiated clinical studies of volasertib in the treatment of aggressive lymphoid malignancies. A Request for Proposals (RFP) is available by clicking the link below. The document clearly outlines the scope and process that will be followed for the submission of proposals.  In brief, investigators are asked to submit short proposals detailing proposed studies. The overall aim of this RFP is to develop innovative studies of volasertib in the treatment of aggressive lymphoid malignancies including acute lymphoblastic leukemia, aggressive lymphoma histologies (including Hodgkin lymphoma), and multiple myeloma. It is hoped that the proposals submitted in response to this RFP will prove useful in guiding the further development of volasertib. Collaborative studies between NCCN Member Institutions are encouraged.
Proposals are due by 5:00 PM EDT, Thursday, October 30, 2014. Electronic submission of proposals is available by clicking the link provided below. For additional information, please contact Doreen Walker, Administrative Assistant, Oncology Research Program, at 215.690.0565 or via e-mail at Walker@nccn.org.

Learn More>>

Connecticut DPH Biomedical Research Request for Proposals

The Connecticut Department of Public Health is seeking proposals for biomedical research projects in the fields of heart disease, cancer and other tobacco-related diseases, Alzheimer's disease, stroke and diabetes.


Application Deadline: September 30, 2014

Learn More>>


Prostate Cancer Foundation 2014 PCF Global Treatment Sciences Challenge Awards

Grants of up to $1 million over 2-3 years will be awarded for research projects related to lethal prostate cancer. (PCF expects to fund 5-10 of these awards.)  Priority will be given to high risk, first-in-field, and currently unfunded projects. Funding will support the correlative research around either clinical trials of novel agents or strategies of standard of care. The foundation's emphasis is on developing or validating biomarkers that guide therapy in patients or further understanding of the mechanism by which therapies work. While the focus is on research in humans, the actual trials or treatments themselves will not be supported. Human samples are highly preferred, although at times model systems might be required to complement the understanding of an important mechanism.

Application Deadline: September 22, 2014

Learn More >> (PDF)


National Cancer Institute Outstanding Investigator Award
The NCI is pleased to announce the Outstanding Investigator Award (OIA) funding opportunity announcement.  The OIA will support investigators with outstanding records of productivity in cancer research with up to $600,000 in direct costs per year for 7 years to provide funding stability.  NCI anticipates making about 50 awards annually.
The OIA will allow funded investigators the freedom to embark on long-term projects of unusual potential in cancer research; the opportunity to take greater risks and be more adventurous in their lines of inquiry; and sufficient time to develop new techniques. 
Applications must be submitted by Institutions who have nominated a Program Director/Principal Investigator (PD/PI) with outstanding productivity in cancer research as a recipient of NCI grant(s) for at least the past 5 years. The PD/PI will be expected to commit at least 50% of his/her research activities to the OIA; the Institution will be expected to commit at least 20% salary support.

Letter of Intent Due Date: September 20, 2014  
Please contact Daniel DiMaio if interested in submitting a LOI from Yale Cancer Center.
Learn More >> 

Center for Cancer Research Clinical Investigator Development Program
The Center for Cancer Research (CCR), a Division of the National Cancer Institute (NCI), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), is pleased to announce its annual call for applications for Clinical Investigator Development Program (CIDP). This is an exciting training opportunity intended for physicians interested in dedicating their careers to clinical research. Candidates may be U.S. citizens, permanent residents or possess (or be eligible for) the appropriate work visa and must have successfully completed subspecialty training at a U.S.-accredited institution in appropriate fields.
Application Deadline: October 30, 2014
Learn More >>

YCC/SCH Grants for Small Projects to Improve Patient Care

Yale Cancer Center and Smilow Cancer Hospital at Yale-New Haven are pleased to announce a new program to fund small projects to improve patient care at Smilow Cancer Hospital. Monies for this program have come through our “Closer to Free” fund. Any employee at Smilow Cancer Hospital who develops a small project may apply by submitting an application for review. Projects can range from a patient education program to stress management for staff. In order to be eligible, the employee must be sponsored by a current Cancer Center Member. A listing of active cancer center members is on the web site.

Grant Details

Amount: $2,500 to $5,000 each

Eligibility: Employees of Smilow Cancer Hospital at Yale-New Haven

Sponsorship: Member of Yale Cancer Center

Application: Limited to 3 pages, typed, double spaced; plus budget with justification (3 copies)

- Application sheet: Project Due Date

- Project Description

- Budget

- Budget Justification

Submit to Renee Gaudette: renee.gaudette@yale.edu

For questions, contact Dr. Ruth McCorkle by email: ruth.mccorkle@yale.edu


Damon Runyon Physician-Scientist Training Award Overview
Physician-scientists who are both clinically trained and expert researchers are essential to the successful translation of scientific discovery into more effective patient therapies. They have the unique capacity to blend their insights from treating patients and working in the laboratory in a way that enables and accelerates medical advances. However, the pipeline of physician-scientists is dwindling. The decline in this vital cadre of cancer researchers is occurring at a time when cancer research holds the greatest promise of improving survival and quality of life among cancer patients. A growing shortage of physician-scientists means that major laboratory research discoveries will progress to patient application ever more slowly. If the shortage continues unabated, some may not reach patient application at all, thus presenting a crisis in cancer research.
The award will be for a period of four years. Funding will be allocated to the awardee’s institution each year for the support of the scientist.  Funds are to be used for stipend and/or research expenses. No part of this grant can be used for indirect costs or institutional overhead.
Year 1 - $100,000
Year 2 - $110,000
Year 3 - $120,000
Year 4 - $130,000
(Total $460,000)*
*Awardees still in their ACGME training years will be paid an award amount commensurate with their institutional salary based on post-graduate year (i.e., PGY6 salary). Upon completion of that training, the award amount will increase to $100,000, with a $10,000 increase for each subsequent year of the Damon Runyon award.

Application Deadline: December 1, 2014
Learn More>>

Ruth McCorkle Oncology Advanced Practice Provider Award

This annual recognition from Yale Cancer Center/Smilow Cancer Hospital will be presented at the YCC Conclave on Monday, November 24, 2014. 
Please consider nominating yourself or a colleague for this award.  It is a unique opportunity to recognize the contributions of our APP colleagues who contribute so much to oncology patient care.
Nominations will be evaluated and the recipient selected by the YCC/Smilow Leadership.  Please submit no later than Friday, October 24, 2014.

Nomination Form>> 


Women’s Research Center at Yale Pilot Project Program

Now in its 17th year, Women’s Health Research at Yale has provided $4.6 million in Pilot Project Program funding, and the results of these seed grants to Yale researchers have generated more than $56 million in new external funding for Yale laboratories and clinical research settings.

Women’s Health Research at Yale 2014-2015 Pilot Project Program offers the following research funds:
·       Pilot Project Awards: Up to $35,000 over one or two years for research designed to meet a clear need in advancing women’s health.
·        Wendy U. & Thomas C. Naratil Pioneer Award: Up to $50,000 in funding over one or two years to initiate new, highly inventive research or to achieve a major breakthrough in ongoing research where funding is needed to achieve its aims. 

All studies selected for funding must demonstrate innovative approaches to major women’s health challenges, and describe a clear path to implementation for clinical or public health benefit.
The projects funded by Women’s Health Research at Yale span a wide array of research topics on gender-related health conditions.  For a list of topics, please visit the Research Findings section of our website -

For both awards, Letters of Intent are due: Wednesday, October 29, 2014 (noon)
All full-time Yale faculty members are eligible to apply.

Learn More>>